A Aralex Aachen research explorer

Hailu Chen Sign in to save

ORCID 0009-0006-1288-4001 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

0

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (2)

4× Alkermes, Inc
1× Alkermes, Waltham, MA, USA

Papers 5 stored

All · Aachen affiliation only

Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial
2026 The Lancet Neurology article Neuroscience Sleep and Wakefulness Research

0

citations
Improvement in Patient-reported Disease Severity, Cognitive Functioning, and Fatigue in Patients With Narcolepsy Type One Treated With Alixorexton, an Orexin Two Receptor Agonist, in the Vibrance-1 Phase Two Study (P6-14.002)
2026 Neurology article Neuroscience Sleep and Wakefulness Research

0

citations
0724 Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton in Patients with Narcolepsy Type 1: The Phase 2 Vibrance-1 Study
2026 SLEEP article Neuroscience Sleep and Wakefulness Research

0

citations
0729 Improvements in Quality of Life in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton
2026 SLEEP conference-abstract Neuroscience Sleep and Wakefulness Research

0

citations
0747 Alixorexton Improved Patient-Reported Disease Severity, Cognitive Functioning, and Fatigue in Patients with Narcolepsy Type 1 in the Vibrance-1 Study
2026 SLEEP conference-abstract Neuroscience Sleep and Wakefulness Research

0

citations

5 results